Physician

David Neal Schwartz, MD, FACG

According to 2025 Medicare claims, David Schwartz, MD, FACG (NPI: 1588649743) practices gastroenterology in the Burlington-South Burlington, VT market, with the plurality of this provider's patient population coming from Chittenden, VT. This provider's primary affiliated billing organization is ASSOCIATES IN GASTROENTEROLOGY, PLLC (NPI: 1346496783; TIN: 261603320) and primary practice location at 05446-4460.

Schwartz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 338 traditional Medicare patients, billed 2,888 HCPCS/CPT codes, and received $95,627 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 708 prescription claims across 266 beneficiaries totaling $204,911 in drug costs, led by Xifaxan (Rifaximin). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $51,787 to $95,627. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $201,779 to $204,911. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$48K$96K2015 Medicare payment: $51,787 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $46,163 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $48,305 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $52,060 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $56,440 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $52,191 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $63,067 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $55,946 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $58,200 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $95,627 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015266394$51,787
2016269358$46,163
2017273517$48,305
2018300567$52,060
2019324523$56,440
2020310425$52,191
2021334463$63,067
2022291428$55,946
2023322437$58,200
20243382,888$95,627

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$173K$347K2015 Drug cost: $201,779 (USD; Tot_Drug_Cst)2016 Drug cost: $158,037 (USD; Tot_Drug_Cst)2017 Drug cost: $133,802 (USD; Tot_Drug_Cst)2018 Drug cost: $114,429 (USD; Tot_Drug_Cst)2019 Drug cost: $100,675 (USD; Tot_Drug_Cst)2020 Drug cost: $118,499 (USD; Tot_Drug_Cst)2021 Drug cost: $346,706 (USD; Tot_Drug_Cst)2022 Drug cost: $304,149 (USD; Tot_Drug_Cst)2023 Drug cost: $214,826 (USD; Tot_Drug_Cst)2024 Drug cost: $204,911 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015183447$201,779
2016114321$158,037
2017130420$133,802
2018162440$114,429
2019211545$100,675
2020192591$118,499
2021228621$346,706
2022174542$304,149
2023164512$214,826
2024266708$204,911

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare8080$198
G0105Colorectal cancer screening; colonoscopy on individual at high risk2626$170
G0121Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk7474$169
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more6781$125
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope3737$75

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XifaxanRifaximin13370$37,952
MotegrityPrucalopride Succinate311,890$32,373
LinzessLinaclotide491,770$30,862
MesalamineMesalamine452,760$18,288
Dexlansoprazole DrDexlansoprazole191,710$9,034

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for David Neal Schwartz, MD, FACG?

Tedicare shows public-source Medicare data for David Neal Schwartz, MD, FACG (NPI 1588649743), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Neal Schwartz, MD, FACG have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Neal Schwartz, MD, FACG?

David Neal Schwartz, MD, FACG is linked to ASSOCIATES IN GASTROENTEROLOGY, PLLC (billing NPI 1346496783) in the available physician profile data.

Does David Neal Schwartz, MD, FACG have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.